The former MSL regional leader reemerges as head of communications at Japan’s largest pharma company.
AstraZeneca’s “Take it from a Fish” took the top prize.
Friday’s no-nivolumab news event disappointed some, but analysts generally rooted for BMS, which saw year-end sales fall 7%, because of anticipated immuno-oncology success.
Get the most out of
Register for free and enjoy unlimited access to: